Fundraising FoxImcyse
1 known investors
Find your way into Imcyse
Sign up to see every warm intro you have to Imcyse
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Imcyse team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Imcyse is a clinical-stage biopharmaceutical company developing a class of specific immunotherapies for severe autoimmune diseases using its ImotopeTM platform, which produces synthetic peptides based on natural proteins to recalibrate the patient's immune system. Its pipeline targets indications including Type 1 Diabetes, Multiple Sclerosis, Rheumatoid Arthritis, Neuromyelitis Optica, and Celiac Disease.
Investors · 1
Frequently asked questions
- What does Imcyse do?
- Imcyse is a clinical-stage biopharmaceutical company developing a class of specific immunotherapies for severe autoimmune diseases using its ImotopeTM platform, which produces synthetic peptides based on natural proteins to recalibrate the patient's immune system. Its pipeline targets indications including Type 1 Diabetes, Multiple Sclerosis, Rheumatoid Arthritis, Neuromyelitis Optica, and Celiac Disease.
- Who are Imcyse's investors?
- Imcyse's investors include Épimède.